Mercaptopurine is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Mercaptopurine is used to treat certain types of leukemia. Mercaptopurine is sometimes given with other cancer medications.

Mercaptopurine belongs to Anti-Cancer Therapeutic Category.

Aarti Healthcare Division of Aarti Industries Limited manufactures Mercaptopurine with an annual capacity of 30000 Kgs.

Mercaptopurine is available in the following Specifications/Grades.

Specification BP/EP/USP
EDMF (CTD) Available
USDMF 22971


One of the principles that enables Aarti to offer our customers the utmost in supply reliability and to further consolidate our competitive position is our backward integration of all the key intermediates that go into manufacturing of APIs.

Bicalutamide Ifosfamide Cyclophosphamide
Mesna Mercaptopurine Azathioprine


Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.